theMednetRegister

Psychiatry

General Hepatology   

Questions discussed in this category

How do you counsel patients on the risks vs benefits of naltrexone for alcohol use disorder with persistently elevated liver enzymes?
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
2 Answers available
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...
5 Answers available


Papers discussed in this category

Scientific reports, 2023 Nov 28
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.
JCI insight, 2023 Jun 22
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission.
JHEP reports : innovation in hepatology, 2024 Apr 10
Safety of naltrexone in patients with cirrhosis.

Related Topics in Psychiatry

Copyright © 2025 theMednet
All Rights Reserved.